Biotech Distributor Announces Expansion of New Sales Division

Share Article

Biotherapeutics Distributor BDI Pharma has expanded its Specialty Sales Division which focuses primarily on the growing physician market for specialty pharmaceuticals. This continued investment in resources is further evidence of BDI’s forward focus and commitment to the industry, as well as to creating new job opportunities.

News Image
This combination [of growth], along with several new platforms recently announced, allows BDI Pharma to continue to be one of the industry's most innovative specialty pharmaceutical distributors while continuing to create new jobs in a struggling economy.

BDI Pharma, Inc. (BDI), the nation’s fastest growing national distributor of specialty biotherapeutics, announced the expansion of its Specialty Sales Division which has been created specifically to serve the growing needs of the physician specialty market. “The continued enhancement of this strategic initiative highlights BDI Pharma’s targeted focus to the expanding industry segment that not only treats disease states that have historically used our core products, but is increasing its demand for injectable specialty biopharmaceuticals,” stated Angela Phillips, Director of Specialty Divisions for BDI Pharma. “With the manufacturing community’s biopharmaceutical offerings to a breadth of physician specialties representing an ever increasing percentage of the market,” added Ed Steres, VP of Strategic Partnerships, “we at BDI Pharma feel an obligation to our trade partners to maintain the promotion and sales momentum we have established through our specialized physician sales force, while offering the same level of service we have provided to all other classes of trade since our founding.”

“As BDI continues its growth in the specialty pharmaceutical marketplace, our core business of plasma related products continues to increase as well,” stated Claude Ferry, VP of Sales for BDI Pharma. “This exciting combination, along with several new platforms recently announced, allows BDI Pharma to continue to be one of the industry's most innovative specialty pharmaceutical distributors while continuing to create new jobs in a struggling economy.”

About BDI Pharma, Inc.

Since 1995, BDI Pharma has defined its customer-centric approach to serving the nation's healthcare community through innovative supply solutions, unparalleled customer service, extensive product knowledge, 24/7 emergency availability and urgent-need delivery. An open-access resource for reference material, educational literature, market data and online ordering, bdipharma.com (ivig.com) has become an industry-renowned point of reference. Proprietary programs for specialty veterinarians -- 4legpharma.com; product consignment -- consignadvantage.com; flu vaccine pre-booking and general vaccine ordering -- securivax.com; and purchasing/reward programs -- qoreprogram.com and securigam.com round out a family of solutions tailored to the needs of the healthcare community at large.

BDI Pharma’s portfolio includes branded and generic specialty pharmaceuticals, chemotherapy products, vaccines, albumin, IVIG, coagulation factors, high-titer or “hyper” immune globulins, and other specialty injectables. BDI Pharma is recognized as an “ADR,” or Authorized Distributor of Record, for all of the manufacturers it represents.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brad Davis
Visit website